How many insider declarations has Schwartz Aharon filed?

Schwartz Aharon has filed 3 public insider declarations with SEC (Form 4).

What is Schwartz Aharon's role?

Schwartz Aharon's reported role is not specified by the regulator across the filings.

Which companies does Schwartz Aharon report trades for?

Schwartz Aharon reports trades for Protalix BioTherapeutics, Inc..

What is Schwartz Aharon's declared buy vs sell volume?

Across the available history, declared buys total 326k€ and disposals 0.

← Executives ★ Sign in to follow

SA

Schwartz Aharon

·SEC (Form 4)

Protalix BioTherapeutics, Inc.

0

Total declarations

0

Company

€325,934

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+55.3%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the full record of transactions filed by Schwartz Aharon. Director active across 1 company, notably Protalix BioTherapeutics, Inc.. Aggregated, 3 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €326k. Activity tracked since 3 January 2023. The latest transaction was disclosed on 10 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Schwartz Aharon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Protalix BioTherapeutics, Inc. (US)

Declarations3 total

◆

Schwartz Aharon

DirectorExecutives3 Sept 2025Protalix BioTherapeutics, Inc.

0SEC ↗

7,500 sharesCommon StockSEC:0001415889-25-023704:0

▲

Schwartz Aharon

DirectorExecutives10 Jun 2025Protalix BioTherapeutics, Inc.

$205,88421SEC ↗

129,000 shares@ US$1.59655.2% of flowCommon StockSEC:0001415889-25-021494:0

Canonical exit: 8 Sept 2025 (T+90)

▲

Schwartz Aharon

DirectorExecutives3 Jan 2023Protalix BioTherapeutics, Inc.

$155,81523SEC ↗

110,000 shares@ US$1.4165100.0% of flowCommon StockSEC:0001104659-23-001495:0

Canonical exit: 3 Apr 2023 (T+90)

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

SA

Schwartz Aharon

·SEC (Form 4)

Protalix BioTherapeutics, Inc.

0

Total declarations

0

Company

€325,934

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+55.3%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the full record of transactions filed by Schwartz Aharon. Director active across 1 company, notably Protalix BioTherapeutics, Inc.. Aggregated, 3 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €326k. Activity tracked since 3 January 2023. The latest transaction was disclosed on 10 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.